Retrospective Real World Oxbryta® Data Collection and Analysis Study

NCT04930328 · clinicaltrials.gov ↗

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Oxbryta® (voxelotor) 500-mg Tablets

Sponsor

Pfizer